Search Results

HRP19 Management of Change Manager's Guide - Appendix 8 Outcome of Consultation - Changes Letter.docx

Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.pdf

Freedom of information disclosure relating to collaborative working with pharmaceutical companies

Tier 3 Specialist Weight Management Service Operational SOP (S157)

The guidance defines what the patient journey through the Tier 3 Specialist Weight Management Service should look like, including: • How referrals are received • How referrals out of the service are completed (to Tier 2 and Tier 4 services) • Clinical thresholds and triage criteria • Patient flow and program content • Prescribing initiation and transition points • MDT roles and responsibilities • Discharge process It also aims to ensure equitable access, clinical safety and consistency in triage and discharge decisions across localities.

Disclosure Ref 2025255 - Guidelines and policies relating to translation and Interrupting services.doc

Freedom of information disclosure relating to guidelines and policies relating to translation and Interrupting services

Corporate Framework August 2025

Corporate Framework August 2025

0535 - Anticoagulation Maintenance Referral Form

0535 - Anticoagulation Maintenance Referral Form

0003 - Continuing Health Care Consent and Basic Information Form

0003 - Continuing Health Care Consent and Basic Information Form

0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19 (P69)

0165 - IPC Terminal Cleaning Schedule for Outpatient areas during COVID-19

1187 - Enhanced Observation Competency Check List

1187 - Enhanced Observation Competency Check List

L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Information for patients with venous leg ulcers

L268 - Use of steroid ointments and creams in the treatment of varicose eczema - Patient Information Leaflet for patients with venous leg ulcers.